CDSCO Compliance: New Order on Self Reporting of Adverse Events
New Delhi, 15 May 2024 – The Central Drugs Standard Control Organisation (CDSCO), under the Ministry of Health & Family Welfare, has issued a new circular (File No. MED-12/30/2024-eoffice) mandating strict compliance with post-market surveillance (PMS) requirements for all medical device license holders. This directive aims to enhance patient safety and ensure the quality and […]